Hologic (HOLX) Reports In-Line Q2 EPS; Lowers Rev Guidance, Maintains EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. DAL

Go back to Hologic (HOLX) Reports In-Line Q2 EPS; Lowers Rev Guidance, Maintains EPS

Hologic Announces Financial Results for Second Quarter of Fiscal 2018

May 2, 2018 4:01 PM EDT

MARLBOROUGH, Mass., May 2, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal second quarter ended March 31, 2018.

Revenue of $789.3 million increased 10.3%, or 8.3% in constant currency, compared to the prior year period.  Excluding the acquired medical aesthetics and divested blood screening businesses, revenue increased 4.8%, or 2.6% in constant currency. 

GAAP diluted earnings per share (EPS) of ($2.46) decreased $4.30 compared to the prior year period, primarily due to non-cash impairment charges for goodwill and in-process research and development of $685.7 million and $46.0 million, respectively, related to Hologic's Cynosure... More